Doximity, Inc. Logo

Doximity, Inc.

DOCS

(2.0)
Stock Price

40,78 USD

13.27% ROA

14.91% ROE

45.62x PER

Market Cap.

5.408.115.646,00 USD

1.73% DER

0% Yield

29.39% NPM

Doximity, Inc. Stock Analysis

Doximity, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Doximity, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 DER

The stock has a low debt to equity ratio (2%), which means it has a small amount of debt compared to the ownership it holds

3 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

4 ROE

ROE in an average range (12.62%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 Buffet Intrinsic Value

The company's stock seems undervalued (232) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

6 PBV

The stock's elevated P/BV ratio (4.84x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

Doximity, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Doximity, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Doximity, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Doximity, Inc. Revenue
Year Revenue Growth
2019 85.695.000
2020 116.388.000 26.37%
2021 206.897.000 43.75%
2022 343.548.000 39.78%
2023 419.052.000 18.02%
2024 454.448.000 7.79%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Doximity, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 27.499.000
2020 32.435.000 15.22%
2021 43.873.000 26.07%
2022 62.350.000 29.63%
2023 80.186.000 22.24%
2024 79.832.000 -0.44%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Doximity, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 7.341.000
2020 7.442.000 1.36%
2021 16.492.000 54.88%
2022 35.746.000 53.86%
2023 36.745.000 2.72%
2024 35.864.000 -2.46%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Doximity, Inc. EBITDA
Year EBITDA Growth
2019 7.472.000
2020 23.063.000 67.6%
2021 57.005.000 59.54%
2022 118.576.000 51.93%
2023 135.391.000 12.42%
2024 209.072.000 35.24%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Doximity, Inc. Gross Profit
Year Gross Profit Growth
2019 74.806.000
2020 101.488.000 26.29%
2021 175.701.000 42.24%
2022 303.761.000 42.16%
2023 365.562.000 16.91%
2024 403.412.000 9.38%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Doximity, Inc. Net Profit
Year Net Profit Growth
2019 7.833.000
2020 29.737.000 73.66%
2021 50.210.000 40.77%
2022 154.783.000 67.56%
2023 112.818.000 -37.2%
2024 122.408.000 7.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Doximity, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 0
2020 0 0%
2021 0 0%
2022 1 0%
2023 1 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Doximity, Inc. Free Cashflow
Year Free Cashflow Growth
2019 14.116.000
2020 21.955.000 35.7%
2021 78.363.000 71.98%
2022 120.878.000 35.17%
2023 173.418.000 30.3%
2024 11.619.000 -1392.54%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Doximity, Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 15.306.000
2020 26.199.000 41.58%
2021 82.973.000 68.42%
2022 126.575.000 34.45%
2023 179.602.000 29.52%
2024 12.898.000 -1292.48%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Doximity, Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 1.190.000
2020 4.244.000 71.96%
2021 4.610.000 7.94%
2022 5.697.000 19.08%
2023 6.184.000 7.88%
2024 1.279.000 -383.5%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Doximity, Inc. Equity
Year Equity Growth
2020 1.136.000
2021 66.743.000 98.3%
2022 878.594.000 92.4%
2023 966.116.000 9.06%
2024 871.467.000 -10.86%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Doximity, Inc. Assets
Year Assets Growth
2020 138.920.000
2021 251.719.000 44.81%
2022 991.357.000 74.61%
2023 1.136.888.000 12.8%
2024 1.025.571.000 -10.85%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Doximity, Inc. Liabilities
Year Liabilities Growth
2020 137.784.000
2021 184.976.000 25.51%
2022 112.763.000 -64.04%
2023 170.772.000 33.97%
2024 154.104.000 -10.82%

Doximity, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.32
Net Income per Share
0.64
Price to Earning Ratio
45.62x
Price To Sales Ratio
12.06x
POCF Ratio
33.96
PFCF Ratio
33.73
Price to Book Ratio
6.45
EV to Sales
11.86
EV Over EBITDA
32.97
EV to Operating CashFlow
32.13
EV to FreeCashFlow
33.14
Earnings Yield
0.02
FreeCashFlow Yield
0.03
Market Cap
5,41 Bil.
Enterprise Value
5,31 Bil.
Graham Number
8.05
Graham NetNet
3.37

Income Statement Metrics

Net Income per Share
0.64
Income Quality
1.34
ROE
0.13
Return On Assets
0.14
Return On Capital Employed
0.17
Net Income per EBT
0.79
EBT Per Ebit
1.12
Ebit per Revenue
0.33
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0.19
Stock Based Compensation to Revenue
0.12
Gross Profit Margin
0.89
Operating Profit Margin
0.33
Pretax Profit Margin
0.37
Net Profit Margin
0.29

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.86
Free CashFlow per Share
0.83
Capex to Operating CashFlow
-0.03
Capex to Revenue
-0.01
Capex to Depreciation
-0.48
Return on Invested Capital
0.12
Return on Tangible Assets
0.13
Days Sales Outstanding
79.15
Days Payables Outstanding
4.91
Days of Inventory on Hand
20.34
Receivables Turnover
4.61
Payables Turnover
74.39
Inventory Turnover
17.94
Capex per Share
-0.03

Balance Sheet

Cash per Share
3,78
Book Value per Share
4,51
Tangible Book Value per Share
4.01
Shareholders Equity per Share
4.51
Interest Debt per Share
0.05
Debt to Equity
0.02
Debt to Assets
0.01
Net Debt to EBITDA
-0.58
Current Ratio
7
Tangible Asset Value
0,77 Bil.
Net Current Asset Value
0,71 Bil.
Invested Capital
0.02
Working Capital
0,74 Bil.
Intangibles to Total Assets
0.09
Average Receivables
0,10 Bil.
Average Payables
0,00 Bil.
Average Inventory
3344500
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Doximity, Inc. Dividends
Year Dividends Growth

Doximity, Inc. Profile

About Doximity, Inc.

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

CEO
Mr. Jeffrey A. Tangney
Employee
977
Address
500, 3rd Street
San Francisco, 94107

Doximity, Inc. Executives & BODs

Doximity, Inc. Executives & BODs
# Name Age
1 Mr. Perry Scott Gold
Head of Investor Relations
70
2 Mr. Paul Jorgensen
Chief Revenue Officer
70
3 Mr. Jey Balachandran
Chief Technology Officer
70
4 Ms. Anna Bryson
Chief Financial Officer
70
5 Mr. Bruno Miranda
Senior Vice President of Engineering
70
6 Ms. Shari Buck
Co-founder and SVice President People & Ops
70
7 Jim Rivas
Head of Corporate Communications
70
8 Ms. Jennifer W. Chaloemtiarana
General Counsel & Corporate Secretary
70
9 Mr. Jeffrey A. Tangney
Co-Founder, Chief Executive Officer & Chairperson
70
10 Dr. Nate Gross M.D.
Co-Founder & Chief Strategy Officer
70

Doximity, Inc. Competitors